Nevertheless, this latter observation does not preclude that SGLT2 inhibition improves kidney oxygenation in patients with diabetes, who present multiple hyperglycemia-associated renal pathophysiological disturbances, among which a reduced cortical oxygenation. This evidence concerns the gene SLC5A2 and diabetes mellitus.